Abstract：
OBJECTIVE: Analyze the usefulness of the midline catheter in terms of efficacy and safety for treatments lasting more than 3 days in the neonatal population requiring admission to the NICU.
METHODS: Analytical and observational of a prospective cohort (December 2021-November 2023) compared to a historical cohort (January 2020-November 2021).
METHODS: 9-bed Neonatal Intensive Care Unit (NICU, level III hospital.
METHODS: 288, 66 midline group and 222 control group.
METHODS: newborns from 24 to 42 weeks of gestation who required short peripheral or midline cannulation and treatment longer than 3 days.
METHODS: Follow-up during NICU stay and comparison with retrospective data from a historical cohort.
METHODS: Sociodemographics, success rate (permanence of the same vascular catheter without complications until finish the prescribed treatment), number of catheters, cannulation rate per patient, indwell time, complications.
RESULTS: The midline group showed a higher success rate (54.2% vs 5.6%, p < 0.001), a lower number of canalizations per patient (p < 0.001), a longer indwell time (p < 0.001) and a lower number of extravasations (p < 0.001).
CONCLUSIONS: The midline catheter has advantages over short peripheral catheters, being a useful alternative in terms of efficacy and safety for treatments lasting more than 3 days in the neonatal population that requires admission to the NICU.
METHODS: Analytical and observational of a prospective cohort (December 2021-November 2023) compared to a historical cohort (January 2020-November 2021).
METHODS: 9-bed Neonatal Intensive Care Unit (NICU, level III hospital.
METHODS: 288, 66 midline group and 222 control group.
METHODS: newborns from 24 to 42 weeks of gestation who required short peripheral or midline cannulation and treatment longer than 3 days.
METHODS: Follow-up during NICU stay and comparison with retrospective data from a historical cohort.
METHODS: Sociodemographics, success rate (permanence of the same vascular catheter without complications until finish the prescribed treatment), number of catheters, cannulation rate per patient, indwell time, complications.
RESULTS: The midline group showed a higher success rate (54.2% vs 5.6%, p < 0.001), a lower number of canalizations per patient (p < 0.001), a longer indwell time (p < 0.001) and a lower number of extravasations (p < 0.001).
CONCLUSIONS: The midline catheter has advantages over short peripheral catheters, being a useful alternative in terms of efficacy and safety for treatments lasting more than 3 days in the neonatal population that requires admission to the NICU.
摘要：
目的：分析中线导管在需要入住NICU的新生儿群体中持续3天以上治疗的有效性和安全性。
方法：对前瞻性队列（2021年12月至2023年11月）与历史队列（2020年1月至2021年11月）进行分析和观察。
方法：9张病床的新生儿重症监护病房（NICU，三级医院。
方法：288、66中线组和222对照组。
方法：妊娠24至42周的新生儿，需要短的外周或中线插管和治疗时间超过3天。
方法：在NICU住院期间进行随访，并与来自历史队列的回顾性数据进行比较。
方法：社会人口统计学，成功率（在完成规定的治疗之前，相同血管导管的持久性无并发症），导管数量,每位患者的插管率，indwell时间,并发症。
结果：中线组成功率更高（54.2%vs5.6%，p<0.001)，每位患者的管道数量较低(p<0.001)，较长的充盈时间（p<0.001）和较低的外渗次数（p<0.001）。
结论：中线导管优于短外周导管，在需要进入NICU的新生儿群体中持续超过3天的治疗方面，是一种有用的替代方法。
方法：对前瞻性队列（2021年12月至2023年11月）与历史队列（2020年1月至2021年11月）进行分析和观察。
方法：9张病床的新生儿重症监护病房（NICU，三级医院。
方法：288、66中线组和222对照组。
方法：妊娠24至42周的新生儿，需要短的外周或中线插管和治疗时间超过3天。
方法：在NICU住院期间进行随访，并与来自历史队列的回顾性数据进行比较。
方法：社会人口统计学，成功率（在完成规定的治疗之前，相同血管导管的持久性无并发症），导管数量,每位患者的插管率，indwell时间,并发症。
结果：中线组成功率更高（54.2%vs5.6%，p<0.001)，每位患者的管道数量较低(p<0.001)，较长的充盈时间（p<0.001）和较低的外渗次数（p<0.001）。
结论：中线导管优于短外周导管，在需要进入NICU的新生儿群体中持续超过3天的治疗方面，是一种有用的替代方法。
